Filing Flows › Comparisons › NHI vs CMRF
National Health Investors vs CIM Group: NHI and CMRF compared
National Health Investors is the larger company: $113M of revenue in its latest quarter (Q3 2026) against $111M for CIM Group (Q2 2026). National Health Investors is growing faster (+26% against -18% a year earlier). National Health Investors is more profitable, with an operating margin of 495.9% against 22.6%.
Where the money goes: NHI and CMRF
National Health Investors (NHI) · Q3 2026
National Health Investors, Q3 2026: revenue $113M (+26% year over year), operating margin 495.9%, net earnings $564M, operating cash flow $48.0M. The chart follows the revenue to costs, profit and cash.
CIM Group (CMRF) · Q2 2026
CIM Group, Q2 2026: revenue $111M (-18% year over year), operating margin 22.6%, net loss $26.0M, operating cash flow −$12.3M. The chart follows the revenue to costs, profit and cash.
| National Health Investors (NHI) | CIM Group (CMRF) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $113M | $111M |
| Revenue growth, Y/Y | +26% | -18% |
| Operating margin | 495.9% | 22.6% |
| Net earnings | $564M | −$26.0M |
| Net margin | 496.6% | -23.4% |
| Operating cash flow | $48.0M | −$12.3M |
| Free cash flow | $41.2M | — |
Questions
Which is bigger, National Health Investors or CIM Group?
National Health Investors is the larger company: $113M of revenue in its latest quarter (Q3 2026) against $111M for CIM Group (Q2 2026).
Is National Health Investors or CIM Group growing faster?
National Health Investors is growing faster (+26% against -18% a year earlier).
Which is more profitable, National Health Investors or CIM Group?
National Health Investors is more profitable, with an operating margin of 495.9% against 22.6%.
More: National Health Investors earnings · how National Health Investors makes money · CIM Group earnings · how CIM Group makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.